356 related articles for article (PubMed ID: 35384591)
61. Molecular predictive and prognostic factors in ependymoma.
Benson R; Mallick S; Julka PK; Rath GK
Neurol India; 2016; 64(2):279-86. PubMed ID: 26954807
[TBL] [Abstract][Full Text] [Related]
62. Ependymoma.
Reni M; Gatta G; Mazza E; Vecht C
Crit Rev Oncol Hematol; 2007 Jul; 63(1):81-9. PubMed ID: 17482475
[TBL] [Abstract][Full Text] [Related]
63. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors.
Ellison DW; Aldape KD; Capper D; Fouladi M; Gilbert MR; Gilbertson RJ; Hawkins C; Merchant TE; Pajtler K; Venneti S; Louis DN
Brain Pathol; 2020 Sep; 30(5):863-866. PubMed ID: 32502305
[TBL] [Abstract][Full Text] [Related]
64. Imaging features to distinguish posterior fossa ependymoma subgroups.
Leclerc T; Levy R; Tauziède-Espariat A; Roux CJ; Beccaria K; Blauwblomme T; Puget S; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Bolle S; Roux A; Pallud J; Provost C; Oppenheim C; Varlet P; Boddaert N; Dangouloff-Ros V
Eur Radiol; 2024 Mar; 34(3):1534-1544. PubMed ID: 37658900
[TBL] [Abstract][Full Text] [Related]
65. Current and Emerging Methods of Management of Ependymoma.
Toescu SM; Aquilina K
Curr Oncol Rep; 2019 Jul; 21(9):78. PubMed ID: 31359299
[TBL] [Abstract][Full Text] [Related]
66. [Verification of the diagnosis of supratentorial ependymomas by real-time PCR].
Galstyan SA; Telysheva EN; Lavrinovich AO; Shaikhaev EG; Snigireva GP; Petrova EI; Gorelyshev SK; Zheludkova OG; Kushel YV; Kumirova EV; Ryzhova MV
Arkh Patol; 2023; 85(3):5-11. PubMed ID: 37272434
[TBL] [Abstract][Full Text] [Related]
67. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
[TBL] [Abstract][Full Text] [Related]
68. [Prognostic factors and results after the combined surgical and radiotherapy treatment of ependymomas].
Grabenbauer GG; Barta B; Erhardt J; Buchfelder M; Thierauf P; Beck JD; Sauer R
Strahlenther Onkol; 1992 Dec; 168(12):679-85. PubMed ID: 1481116
[TBL] [Abstract][Full Text] [Related]
69. The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective.
Lee CH; Chung CK; Ohn JH; Kim CH
J Korean Neurosurg Soc; 2016 Mar; 59(2):83-90. PubMed ID: 26962412
[TBL] [Abstract][Full Text] [Related]
70. Intracranial ependymomas in children.
Undjian S; Marinov M
Childs Nerv Syst; 1990 May; 6(3):131-4. PubMed ID: 2357709
[TBL] [Abstract][Full Text] [Related]
71. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
[TBL] [Abstract][Full Text] [Related]
72. Recent Advances in the Classification and Treatment of Ependymomas.
Leeper H; Felicella MM; Walbert T
Curr Treat Options Oncol; 2017 Aug; 18(9):55. PubMed ID: 28795287
[TBL] [Abstract][Full Text] [Related]
73. Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.
Jünger ST; Andreiuolo F; Mynarek M; Dörner E; Zur Mühlen A; Rutkowski S; von Bueren AO; Pietsch T
Childs Nerv Syst; 2020 Nov; 36(11):2693-2700. PubMed ID: 32474813
[TBL] [Abstract][Full Text] [Related]
74. Ependymoma: results, prognostic factors and treatment recommendations.
McLaughlin MP; Marcus RB; Buatti JM; McCollough WM; Mickle JP; Kedar A; Maria BL; Million RR
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):845-50. PubMed ID: 9531369
[TBL] [Abstract][Full Text] [Related]
75. Childhood ependymoma: a systematic review of treatment options and strategies.
Grill J; Pascal C; Chantal K
Paediatr Drugs; 2003; 5(8):533-43. PubMed ID: 12895136
[TBL] [Abstract][Full Text] [Related]
76. Prognosis by tumor location for pediatric spinal cord ependymomas.
Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
[TBL] [Abstract][Full Text] [Related]
77. Ependymoma of the Spinal Cord in Children: A Retrospective French Study.
Szathmari A; Zerah M; Vinchon M; Dufour C; Gimbert E; Di Rocco F; Chabaud S; Conter C; Mottolese C; Frappaz D
World Neurosurg; 2019 Jun; 126():e1035-e1041. PubMed ID: 30877001
[TBL] [Abstract][Full Text] [Related]
78. [Ependymoma in WHO Classification of Tumours 5th Edition].
Saito R
No Shinkei Geka; 2023 Sep; 51(5):867-875. PubMed ID: 37743338
[TBL] [Abstract][Full Text] [Related]
79. [Intracranial ependymomas. Experience with 86 cases].
Lejeune JP; Dhellemmes P; Dupard T; Combelles G; Delandsheer JM
Neurochirurgie; 1987; 33(2):118-23. PubMed ID: 3600940
[TBL] [Abstract][Full Text] [Related]
80. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
Ramaswamy V; Hielscher T; Mack SC; Lassaletta A; Lin T; Pajtler KW; Jones DT; Luu B; Cavalli FM; Aldape K; Remke M; Mynarek M; Rutkowski S; Gururangan S; McLendon RE; Lipp ES; Dunham C; Hukin J; Eisenstat DD; Fulton D; van Landeghem FK; Santi M; van Veelen ML; Van Meir EG; Osuka S; Fan X; Muraszko KM; Tirapelli DP; Oba-Shinjo SM; Marie SK; Carlotti CG; Lee JY; Rao AA; Giannini C; Faria CC; Nunes S; Mora J; Hamilton RL; Hauser P; Jabado N; Petrecca K; Jung S; Massimi L; Zollo M; Cinalli G; Bognár L; Klekner A; Hortobágyi T; Leary S; Ermoian RP; Olson JM; Leonard JR; Gardner C; Grajkowska WA; Chambless LB; Cain J; Eberhart CG; Ahsan S; Massimino M; Giangaspero F; Buttarelli FR; Packer RJ; Emery L; Yong WH; Soto H; Liau LM; Everson R; Grossbach A; Shalaby T; Grotzer M; Karajannis MA; Zagzag D; Wheeler H; von Hoff K; Alonso MM; Tuñon T; Schüller U; Zitterbart K; Sterba J; Chan JA; Guzman M; Elbabaa SK; Colman H; Dhall G; Fisher PG; Fouladi M; Gajjar A; Goldman S; Hwang E; Kool M; Ladha H; Vera-Bolanos E; Wani K; Lieberman F; Mikkelsen T; Omuro AM; Pollack IF; Prados M; Robins HI; Soffietti R; Wu J; Metellus P; Tabori U; Bartels U; Bouffet E; Hawkins CE; Rutka JT; Dirks P; Pfister SM; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Ellison DW; Taylor MD
J Clin Oncol; 2016 Jul; 34(21):2468-77. PubMed ID: 27269943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
